BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 32410512)

  • 81. Postbiotics Enhance NK Cell Activation in Stress-Induced Mice through Gut Microbiome Regulation.
    Jung YJ; Kim HS; Jaygal G; Cho HR; Lee KB; Song IB; Kim JH; Kwak MS; Han KH; Bae MJ; Sung MH
    J Microbiol Biotechnol; 2022 May; 32(5):612-620. PubMed ID: 35283424
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Gut health benefit and application of postbiotics in animal production.
    Zhong Y; Wang S; Di H; Deng Z; Liu J; Wang H
    J Anim Sci Biotechnol; 2022 Apr; 13(1):38. PubMed ID: 35392985
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa.
    Lawrence GW; Begley M; Cotter PD; Guinane CM
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019270
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Postbiotics as Potential Detoxification Tools for Mitigation of Pesticides.
    Khani N; Noorkhajavi G; Reziabad RH; Rad AH; Ziavand M
    Probiotics Antimicrob Proteins; 2023 Nov; ():. PubMed ID: 37934379
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Biological roles of toll-like receptors and gut microbiota in colorectal cancer.
    Yinhang W; Wei W; Jing Z; Qing Z; Yani Z; Yangyanqiu W; Shuwen H
    Future Microbiol; 2022 Sep; 17():1071-1089. PubMed ID: 35916158
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer.
    Leystra AA; Clapper ML
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703321
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response.
    Sánchez-Alcoholado L; Ramos-Molina B; Otero A; Laborda-Illanes A; Ordóñez R; Medina JA; Gómez-Millán J; Queipo-Ortuño MI
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486066
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Paraprobiotics and Postbiotics of Probiotic
    Teame T; Wang A; Xie M; Zhang Z; Yang Y; Ding Q; Gao C; Olsen RE; Ran C; Zhou Z
    Front Nutr; 2020; 7():570344. PubMed ID: 33195367
    [No Abstract]   [Full Text] [Related]  

  • 89. Can Postbiotics Represent a New Strategy for NEC?
    Mosca F; Gianni ML; Rescigno M
    Adv Exp Med Biol; 2019; 1125():37-45. PubMed ID: 30656552
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Postbiotics in oncology: science or science fiction?
    Kudra A; Kaźmierczak-Siedlecka K; Sobocki BK; Muszyński D; Połom J; Carbone L; Marano L; Roviello F; Kalinowski L; Stachowska E
    Front Microbiol; 2023; 14():1182547. PubMed ID: 37608943
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Postbiotics: an exposition on next generation functional food compounds- opportunities and challenges.
    Suthar P; Kumar S; Kumar V; Sharma V; Dhiman A
    Crit Rev Food Sci Nutr; 2023 Dec; ():1-20. PubMed ID: 38063352
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer.
    Mileo AM; Nisticò P; Miccadei S
    Front Immunol; 2019; 10():729. PubMed ID: 31031748
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways.
    Sankaranarayanan R; Kumar DR; Altinoz MA; Bhat GJ
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260951
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Postbiotics against Obesity: Perception and Overview Based on Pre-Clinical and Clinical Studies.
    Park SJ; Sharma A; Lee HJ
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047387
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Challenges in the production and use of probiotics as therapeuticals in cancer treatment or prevention.
    Mejía-Caballero A; Salas-Villagrán VA; Jiménez-Serna A; Farrés A
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34427674
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells.
    Eslami M; Sadrifar S; Karbalaei M; Keikha M; Kobyliak NM; Yousefi B
    J Gastrointest Cancer; 2020 Sep; 51(3):738-747. PubMed ID: 31735976
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Probiotics and Psychobiotics: the Role of Microbial Neurochemicals.
    Oleskin AV; Shenderov BA
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1071-1085. PubMed ID: 31493127
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer.
    Francescangeli F; De Angelis ML; Zeuner A
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31816977
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment.
    Thoda C; Touraki M
    Microorganisms; 2023 Jul; 11(8):. PubMed ID: 37630458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.